Previously, we have identified a tumor cell-specific peptide, HEW, by panning of phage display libraries on the human colorectal cancer cell line WiDr. In this report we demonstrate that this peptide can modify the infection properties of adenovirus vectors. Increased infectivity of replication-deficient adenovirus 5 vectors in WiDr cells was observed upon genetic insertion of the HEW peptide in the HI loop of the fiber knob. Moreover, whereas the coxsackie and adenovirus receptor (CAR)-ablating fiber mutation S408E abolished apparent infection in CAR-positive WiDr cells, the insertion of HEW completely restored infectivity toward these cells in vitro. To assess whether the de-and re-targeted infection profile was maintained in vivo, the fiber-modified adenovirus vectors were injected intratumorally or intravenously in WiDr tumor-bearing Swiss nu/nu mice. No significant differences in efficiency of infection could be observed suggesting alternative viral uptake mechanisms in vivo. Next, we have included the fiber shaft mutation S* in our studies, which was described to confer a de-targeted phenotype in vivo. Reduced gene transfer due to the S* mutation both in vitro and in vivo could be confirmed. Insertion of HEW in the HI knob loop of shaft-mutated fiber, however, did not rescue infectivity in target cells neither in vitro nor in vivo. We demonstrate the efficient ligand-mediated re-targeting of adenoviral vector infection to the human cancer cell line WiDr. The lack of apparent re-targeting in the in vivo situation is described.
Introduction
Recombinant human adenovirus 5 (Ad5) vectors can deliver transgenes in a variety of dividing and nondividing cell types, a feature that has rendered such vectors interesting as gene transfer vehicles. The Ad5 capsid is mainly composed of penton-base and hexon, with the minor capsid protein pIX exerting a cement function, whereas the trimeric fiber with its fiber shaft and fiber knob domain is protruding from the virion surface. 1 The cellular entry of Ad5 in vitro is well described and occurs via a multiple-step mechanism [1] [2] [3] : first, the globular fiber knob domain, located at the distal end of the fiber homotrimers extending from the 12 capsid vertices, binds to its native cell-surface receptor, the coxsackie and adenovirus receptor (CAR). Following attachment, the Arg, Gly, Asp (RGD) motif of the capsid penton-base interacts with cell-surface a v integrins. This secondary step initiates viral endocytosis within clathrincoated vesicles, with subsequent viral release into the cytoplasm, nuclear translocation and viral replication. Besides CAR and a v integrins, a tertiary receptor-type, heparan sulfate proteoglycans (HSPG), was proposed to play a role in viral infectivity of adenovirus types 2 and 5. 4 In vivo, systemic administration of Ad5-derived replication-deficient vectors in rodents and non-human primates results in sequestration of the virus in the liver with 95% of measurable transduction in liver hepatocytes 5, 6 and uptake by Kupffer cells. 7 Whereas the exact mechanism still needs to be elucidated, liver tropism represents a barrier for selective infection of non-liver target tissue, for example in the context of gene-based cancer therapeutic approaches. High doses of potentially toxic and immunogenic Ad5 vectors would be needed to overcome the liver barrier and facilitate gene transfer to target tissues like tumors and metastases, an unfeasible approach due to safety reasons.
Therefore, strategies are being pursued to circumvent the natural liver tropism of Ad5 vectors (de-targeting) and to add new tissue tropism characteristics (re-targeting). Among various approaches described and reviewed, 8 one is to alter the natural tropism of replication-deficient Ad5 vectors by genetic modifications of the virus capsid. To interfere with CAR binding, Ad5 vectors were developed with modifications in the AB loop of the fiber knob, for example S408E. 9, 10 Ad5 vectors with the S408E mutation are unable to directly interact with CAR. 9, 11 The deletion of the RGD (Arg-Gly-Asp) motif within the penton base was shown to affect not only binding to a v integrin and the subsequent internalization 12 but also the escape of viral particles from the endosomes. 13 Whereas the infection efficiency of Ad5 vectors with the S408E mutation or RGD deletion in cell culture was severely reduced, the liver tropism of these vectors in vivo remained unchanged. 9 , 10 Smith et al. 14 have described the putative HSPG ablating mutation S* with the Lys-Lys-Thr-Lys (KKTK) motif in the fiber shaft being changed to Gly-Ala-Gly-Ala (GAGA). Reduced gene transfer with the resulting vector was not only seen in vitro but also in vivo with 15-fold reduced liver transduction after systemic application.
14 The exchange of the Ad5 fiber shaft by the Ad35 fiber shaft has as well conferred an attenuation of the liver tropism and thus toxicity. 15 Combinations of capsid mutations, comprising CAR-ablating mutations and deletion of the RGD penton base with or without fiber shaft modifications, have been shown to reduce in vivo liver transduction and toxicity. [14] [15] [16] [17] [18] An exhaustive list of de-targeting mutations is presented in Nicklin et al.
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Genetic engineering techniques were further applied to add new tissue tropism characteristics to Ad5 vectors (retargeting). Capsid proteins were genetically modified such that ligands, specific for cells or tissues, were exposed on the viral surface, accessible for their respective receptors. For example, the introduction of a transferrin receptorbinding peptide in the HI loop of fiber knob did facilitate gene transfer to cells overexpressing this receptor type. 19 Insertion of a peptide sequence, selected by phage display panning on primary human venous vascular smooth muscle cells, into the HI loop of fiber knob carrying CAR-ablating mutations rescued and even enhanced gene transfer to these cells in vitro.
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Toward the development of Ad vectors for cancer therapy, we set out to redirect and enhance Ad5 vector infection by virtue of the tumor cell-specific peptide HEW. This peptide was identified by panning of phage display libraries on the human colorectal cancer cell line WiDr. 21 Briefly, cancer cell-specific phages were isolated from complex peptide display phage libraries first by subtracting on 293 cells and then by selecting on various human cancer cells. The 'HEW phage' showed a more than 1000-fold higher binding efficiency for WiDr cells when compared to other human cancer cell lines and wild-type (wt) M13 phage. Here, we describe the generation and functionality of replication-deficient adenovirus vectors carrying the targeting peptide HEW exposed in the fiber knob domain with or without de-targeting mutations. The infection studies were carried out in vitro in the target cell line WiDr. The functionality in vivo was assessed in xenografted Swiss nu/nu mice with subcutaneous WiDr tumors by intratumoral (i.tu.) as well as intravenous (i.v.) injection.
Materials and methods

Cells
The human colorectal cancer cell lines WiDr, CaCo2 and Lovo, the human embryonic kidney cell line 293, the human breast carcinoma cell line MD-MB435 and the human cervix carcinoma cell line HeLa were obtained from the American Type Culture Collection, USA. The cell lines were maintained in Dulbecco's minimal Eagle's medium (DMEM) supplemented with 10% fetal calf serum and antibiotics at 371C in 5% CO 2 . 293-Fiber cells (293-Fb), which constitutively express the adenovirus type 5 fiber protein, have been described elsewhere. 22 Construction of fiber-modified viral genomes Plasmid-borne adenoviral vector genomes or subgenomic sequences were modified genetically using standard molecular biology methods 23 and homologous recombination techniques. 24 The viral genomes utilized in this study are syngeneic except for their fiber sequences. They are all deleted in E1 and E3 and carry a cytomegalovirus immediate early (CMV IE) promoter/enhancer-driven b-galactosidase ¼ -31ession cassette (lacZ) in place of E1. The plasmid-borne viral genomes of AdTG15095 (F-wt), AdTG15096 (F-S408E) and AdTG15094 (F1) are described elsewhere. 9 The plasmid-borne viral genomes of AdTG15748 (F-HEW) and AdTG15751 (F-S408E-HEW) were generated as follows: in order to introduce the HEW peptide (complete amino acid sequence: His-GluTrp-Ser-Tyr-Leu-Ala-Pro-Tyr-Pro-Trp-Phe (HEWSY-LAPYPWF 21 ) in the HI loop of Ad5 fiber knob, a SpeI restriction site was first introduced with the Sculptor in vitro mutagenesis system (Amersham, GE Healthcare Biosciences, Uppsala, Sweden) in fiber gene-containing M13 templates (m13F5knob and m13F5-S408E-knob) using the following antisense oligonucleotides: OTG14499: 5 0 -cgattctttagctgccgggcgccgaggcggaggcggaggcg-3 0 and OTG14509: 5 0 -catagagtatgcacttggactagtgtctcctgtttcctgtg-3 0 . m13F5knob and m13F5-S408E-knob contain Ad5 sequence from nucleotide (nt) 31994 (HindIII) to nt 32991 (SmaI site) with or without S408E mutation. Complementary oligonucleotides coding for the HEW peptide flanked by SpeI extremities (OTG14510: 5 0 -ctagtcacgagtg gagctacctggccccctacccatggttca-3 0 and OTG14511: 5 0 -ctagt gaaccatgggtagggggccaggtagctccactcgtga-3 0 ) were then annealed and ligated into SpeI-linearized m13F5knob and m13F5-S408E-knob plasmids. The 1.1 kb HindIIISmaI fragments containing the modified fibers were then directly introduced by homologous recombination into the BstBI-restricted plasmid-borne genome of AdTG15095. BstBI site had been introduced in pADTG15095 at nucleotide 32940, downstream of the fiber stop codon.
The S* mutation 14 replacing KKTK within the fiber shaft by GAGA was generated by site-directed mutagenesis (QuikChange II XL site-directed mutagenesis kit by Stratagene, La Jolla, CA) of a subgenomic fragment (pTG16383) which was later introduced into BstBIrestricted pAdTG15095 by homologous recombination, resulting in pAdTG16436 (F-S*). To generate pAdTG16685 (F-HEW-S*), a 664 bp SmaI, BstXI fragment from pADTG15748, carrying the fiber-knob-inserted HEW, was inserted by homologous recombination into the BstBI-restricted pAdTG16436.
Virus production and titration Virus propagation, purification and storage were carried out essentially as described elsewhere. 9 Briefly, viral genomes were excised from their plasmid backbone by PacI digestion and then transfected in 293 or 293-Fb cells. Fiber complementation was needed to generate and amplify F-S408E, F-S* and F1 vectors. Viral vectors having thus mutated, wt fiber were amplified in a singleround infection in 293 cells resulting in viral vectors with mutated fiber or no fiber at all. Viral particle (vp) concentration was identified by optical density measurement (1 OD 260 corresponds to 1.1 Â 10 12 vp/ml); infectious unit (IU) titers were determined 16-20 h after infection of 293 cells by staining for b-galactosidase activity in situ. The integrity of the viral genome and the presence of the respective genetic modifications were verified by sequencing and restriction analysis of viral DNA (Hirt DNA).
Western-blot analysis Viral particles (5 Â 10 9 ) were diluted in 2 Â Laemmli buffer, incubated for 5 min at 951C, and run on Trisglycine polyacrylamide gels 8-16% (Invitrogen Life Technologies, Carlsbad, CA), and then transferred to nitrocellulose. Filters were hybridized with either antipenton base (serum SE262, obtained from P Boulanger, Montpellier, France), anti-fiber knob 25 or anti-pIX 26 rabbit polyclonal antibodies. Bound antibodies were detected using a horseradish peroxidase-conjugated donkey anti-rabbit antibody according to the manufacturer's instructions (ECL detection kit, GE Healthcare Biosciences).
In vitro infection studies
Cancer cell lines were seeded in 24-well plates (2 Â 10
5
). The next day, cells were infected with adenovirus vectors at the indicated multiplicity of infection (m.o.i.) in DMEM supplemented with 2% fetal calf serum. We have adjusted the m.o.i. for each cell line such that bgalactosidase activities was around 1 000 000 and 10 000 000 relative light units (RLU) in case of the control vectors. On day 1 after infection cells were lysed in 100 ml 1 Â reporter lysis buffer (Promega Biosciences, Obispo, CA). b-Galactosidase activity in 20 ml lysate was quantified using a luminescent b-galactosidase detection kit (BD Biosciences, Bedford, MA) and expressed as RLU.
In competition experiments, cell culture monolayers were incubated for 30 min at 371C with or without competitor molecules, purified Ad5 knob at 10 mg/ml 27 and/or HEW peptide, fused to polylysin at 3 mg/ml, as described elsewhere 21 before infection with the respective adenovirus vectors. After 24 h, cells were fixed and stained by X-gal to detect LacZ expression in situ.
In vivo experiments Four to 6-week-old female Swiss nu/nu mice were received from Iffa Credo (Saint Germain sur L'Arbresle, France). Tumors were generated by subcutaneous injection of 5 Â 10 6 WiDr cells in 100 ml of Dulbecco's phosphate-buffered saline into the left flank of Swiss nu/nu mice. This resulted in tumors of 100 mm 3 approximately 16 days after injection. Injections (i.tu.) were carried out by single-site injection of 100 ml virus solution into 100 mm 3 tumors. Alternatively, 100 ml virus solution was applied i.v. Two days after injection, mice were euthanized and tumors were recovered to determine the level of b-galactosidase expression using a colorimetric immunoassay for the quantitative determination of bgalactosidase (b-gal enzyme linked immuno sorbent assay (ELISA), Roche, Basle, Switzerland). To this, tumors or liver samples were mechanically homogenized (Polytron, Kinematica) in 1 Â reporter lysis buffer (Promega). The homogenates were centrifuged to pellet cellular debris. The amount of b-gal level in the supernatant was quantified and expressed as pg in 200 ml/mg protein.
Protein concentration was determined using the BCA protein assay kit (Pierce No. 23225) according to the manufacturer's instructions.
Results
Generation of fiber-modified adenovirus vectors with genetically inserted targeting ligand HEW
We have generated a series of fiber-modified replicationdeficient adenovirus vectors, which are summarized in Table 1 . All vectors are deleted in early regions 1 and 3 (E11E31) having in place of E1 a CMV IE promoter/ enhancer-driven b-galactosidase expression cassette. The adenovirus vector AdTG15095 (F-wt) carries the wt fiber protein, whereas AdTG15748 (F-HEW) has the targeting ligand HEW genetically inserted in the fiber knob HI loop between amino acids 545 and 546. The HI loop was chosen since it protrudes outside the fiber trimer. 28 Insertions within this loop are thus less likely to disturb the trimerization of the fiber molecules, essential for virus assembly and infectivity. HEW was as well inserted in the HI loop of fiber proteins carrying the fiber knob mutation S408E (AdTG15751/F-HEW-S408E) or the fiber shaft mutation S* (AdTG16685/F-S*-HEW). AdTG16436 (F-S*) represents the adenovirus vector carrying the fiber shaft mutation S* consisting of a substitution of the 14 Further included in our studies was a fiber-less adenoviral vector (AdTG15094 or F1). 9 No growth disadvantage due to the insertion of HEW in the fiber knob was observed, whereas S408E, S* and even more so F1 reduced the titer of IUs in the virus preparations and thus increased the ratio vp/IU ( Table 1) . The incorporation of fiber molecules in the virus particle was confirmed by Western-blot analysis of purified viruses (Figure 1) . The wt or modified fiber proteins were incorporated into the viral capsid, implying their correct trimerization. As expected, no fiber signal was detected in the case of the fiber-less Ad5 vector F1.
In vitro efficiency of infection
We have tested the in vitro infection efficiency of the above-described Ad5 vectors F-wt (AdTG15095), F-HEW (AdTG15748), F-S408E (AdTG15096), F-HEW-S408E (AdTG15751) and F1 (AdTG15094) Competition experiments in WiDr cells have shown that infection with F-wt was efficiently competed for by soluble fiber knob protein, whereas the infectivity of F-HEW was only marginally inhibited (Figure 2b ). In the presence of free HEW peptide, the gene transfer with F-HEW, but not with F-wt, decreased by 30%. The infection of WiDr cells by F-HEW could only be competed efficiently for by both, knob and HEW peptide. In 293 cells, infections by F-wt and F-HEW were equally well competed for by the knob peptide, no effect was seen with the HEW peptide, as was the case for Hela cells (data not shown). These results suggest a new, specific attachment site provided by the interaction between the HEW peptide and a yet unknown receptor on the surface of target WiDr cells, capable of replacing the interaction between CAR and fiber knob.
Efficiency of gene transfer in vivo
Next, we have tested whether the above-described fiber modifications alter the specificity of gene transfer in the in vivo situation. To this end we have implanted WiDr cells subcutaneously into Swiss nu/nu mice. As soon as the resulting tumors had reached 100 mm 3 , adenoviral vectors with or without HEW insertion and S408E mutation were injected either into the tumor or systemically into the tail vein. Two days later, mice were killed, tumors and livers were homogenized and reporter gene expression was quantified.
Injecting between 8 Â 10 9 and 1 Â 10 11 vp of F-wt locally into the WiDr tumors, a dose-dependent tumor transduction was observed (Figure 3a) . For the subsequent comparison of fiber-modified adenovirus vectors, Incorporation of modified fiber homotrimers in purified adenovirus particles. The various fiber-modified viruses were purified by cesium chloride gradient centrifugation (density 1.34 g/ml). Purified particles (5 Â 10 9 vp) were denatured and run on a 10% poly-acrylamide gel. After transfer to nitrocellulose, filters were hybridized with either polyclonal anti-fiber knob, anti-penton base or anti-pIX antibodies produced in rabbits, and were then treated with horseradish peroxidase-conjugated donkey anti-rabbit antibody. Horseradish peroxidase activity was detected by light emission. (1) AdTG15095 (F-wt), (2) AdTG15748 (F-HEW), (3) AdTG15096 (F-S408E), (4) AdTG15751 (F-HEW-S408E), (5) AdTG15094 (F1), (6) AdTG16436 (F-S*), (7) AdTG16685 (F-S*-HEW).
Targeting of adenovirus vectors
K Rittner et al the non-saturating dose of 2 Â 10 10 vp was chosen. Four independent experiments were carried out with groups of 10 mice in each experiment, the mean results are shown in Figure 3b . No significant differences in gene transfer efficiency could be observed among the adenoviral vectors F-wt, F-HEW, F-S408E and F-HEW-S408E. Neither increase of infection efficiency correlating with the presence of the HEW ligand nor reduced gene transfer associated with the S408E mutation could be claimed after local injection. However, gene transfer was close to background levels with the fiber-less vector. This confirms that the fiber molecule is important for infection and cell entry in vivo.
Toward the systemic application of adenovirus vectors, a first experiment has revealed that a dose of 2 Â 10 10 vp was not sufficient to obtain detectable b-galactosidase levels in the tumor by day 2 p.i. (data not shown). Therefore, we increased the dose to 2 Â 10 11 vp; the Ad5 Figure 4 . No significant differences in gene transfer efficiency were observed among the vectors F-wt, F-HEW, F-S408E and F-HEW-S408E. In all cases, gene transfer into the liver was much more efficient than to the tumor demonstrating the liver tropism of Ad vectors, even in the presence of the S408E mutation. None of the Ad vectors carrying the HEW peptide showed enhanced gene transfer into WiDr tumors. Gene transfer into the liver was comparable among these four vectors. The lack of detargeting effects in the liver due to S408E after i.v. injection confirms earlier results. 9 Gene transfer with F1 was undetectable in liver, and tumor tissue again pointing toward an important role of Ad5 fiber for viral infection in vivo. Thus, in contrast to the in vitro situation, neither detargeting nor re-targeting effects could be demonstrated, both after i.tu. and i.v. injection.
Combination of HEW with S* One explanation for the absence of apparent re-targeting effects in vivo might have been the lack of efficient detargeting from the natural tropism. In the context of an in vivo de-targeted Ad vector, targeting effects might become significant. 
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Therefore, we set out to combine F-HEW with the fiber shaft mutation S* (KKTK to GAGA 14 ) . The S* mutation was described to de-target infection from the natural tropism both in vitro and in vivo. The characteristics of the adenovirus vectors F-S* and F-S*-HEW are delineated in Table 1 . The incorporation of the modified fiber molecules in the virus capsid was confirmed by Westernblot analysis (Figure 1 ). We could confirm reduced gene transfer due to the S* mutation both in vitro and in vivo (Figure 5a and b) . Inserting HEW in the HI loop of fiber molecules with the shaft mutation S* did not rescue infectivity on the target cells WiDr (Figure 5a ) nor upon i.tu. injection in vivo (Figure 5b ). The lack of rescue of infectivity in vitro in WiDr cells questions the capacity of the S* mutation to allow for efficient infection when combined with a targeting ligand.
Discussion
We set out to change the infection tropism of a replicationdeficient Ad5 vector by genetic modification of the fiber molecule with the ultimate goal to infect specifically tumor tissue in vivo. A targeting peptide ligand, HEW, selected on and specific for the human colon cancer cell line WiDr, was introduced in the exposed HI loop of the fiber knob domain to increase infection of WiDr cells in cell culture and to facilitate the specific infection of WiDr-tumors in vivo. The targeting ligand HEW was inserted in wt fiber, as well as in fiber molecules carrying the de-targeting mutations S408E or S*.
In vitro data
In cell culture, the presence of the peptide ligand HEW in the fiber knob domain of a replication-deficient adenovirus vector has conferred increased gene transfer into the CAR-positive target cells WiDr. Equally high infectivity was achieved with an adenovirus vector exposing in its fiber knob both, HEW and the in vitro CAR-ablating mutation S408E, which on its own reduced viral infectivity to background levels. This remarkable in vitro re-targeting effect represents a more than 100-fold enhancement of infectivity of the Ad5 vector F-HEW-S408E compared to F-S408E. Infection of WiDr cells with F-HEW could only be competed for by both, soluble knob and HEW peptide, confirming that WiDr cells expose both, CAR-and an HEW-specific target molecule/ receptor on the cell surface. The interaction between the HEW peptide and its receptor on WiDr cells is capable of replacing the interaction between CAR and fiber knob during viral infection, whereas the presence of the HEW peptide in the fiber knob does not impede efficient infection of cells without a HEW target, for example HeLa and 293 cells. Earlier transfection data with HEW peptide-complexed plasmid DNA have suggested that the interaction of HEW with WiDr cells does not lead to endocytosis, 21 providing only a site for attachment, a feature which parallels the nature of the CAR/fiber knob interaction. Subsequent steps in viral infection in WiDr cells, like uptake and internalization, seem equally efficient no matter whether the virus attachment was mediated by fiber knob/CAR or by fiber knob exposed HEW and its target molecule. The adenovirus infection of the human breast carcinoma cell line MDB-MB435 infection does not seem to be mediated by Fiber/CAR interaction which could be due to the absence of this receptor. In contrast, infection is strongly enhanced by adenovirus vectors exposing the HEW peptide, suggesting the presence of the putative HEW receptor on these cells.
The fiber shaft mutation S* did reduce infectivity in vitro in WiDr and 293 cells. In contrast to the S408E Targeting of adenovirus vectors K Rittner et al mutation, infectivity in vitro in WiDr cells could not be restored by combining the S* mutation in the fiber shaft with a fiber knob carrying the HEW peptide. This might be due to conformational restraints introduced by the S* mutation having an impact on the presentation of the HEW ligand. It might as well be that subsequent steps of virus internalization or endosome escape are affected by the S* mutation. Our results challenge the capacity of the S* mutation to serve as platform for efficient re-targeting when combined with a targeting ligand inserted in the fiber knob domain.
In vivo data
We have assessed viral infection in vivo by local injection of fiber-modified adenovirus vectors into subcutaneously grown WiDr tumors. By this route, the liver tropism of Ad5 vectors was biased and, sheltered from the main blood stream, interactions of viral vectors with tumor tissue was privileged. Nevertheless, we could not observe a significant increase of gene transfer efficiency when injecting vectors with the HEW peptide exposed in the fiber knob domain. The infection profile seemed in the best case attenuated compared to the in vitro data with differences of the mean values lower than the standard deviations and thus not significant. The evidence of an HEW-mediated targeting effect in vivo might have been impeded by the inaccessibility of the HEW receptor, buried within the three-dimensional structure of WiDr tumors, which were grown as a conglomerate most likely with host-derived stroma cells. In addition, the lack of a clear de-targeting effect when injection adenovirus vector F-S408E might have masked an otherwise detectable retargeting effect with F-HEW-S408E.
As observed after local injection, systemic delivery of HEW carrying Ad5 vectors did not lead to enhanced WiDr tumor transduction. In addition, the gene transfer 
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K Rittner et al profile of fiber-modified Ad5 vectors has confirmed earlier observations with respect to the CAR-ablating mutation S408E. 9 Upon i.v. injection there was neither reduction of gene transfer efficiency into the liver nor in the tumor. Gene transfer efficacy was reduced in the case of fiber-less Ad vectors, pointing toward an important role of the fiber molecules during viral infection in vivo.
Primary interaction of adenoviral vectors with cells in vitro occurs via fiber knob and CAR, an interaction that can be abolished by fiber knob mutations like S408E. Given the observation that the S408E mutation has no detargeting effect in vivo on tumors formed by CAR-positive WiDr cells, does this imply that Ad vector infection in vivo is independent of fiber knob CAR interaction? We have observed that tumors made of the CAR-negative murine melanoma cell line B16F0 could be infected by Ad vectors upon i.tu. injection only with low efficiency. Tumors generated from B16F0 cells, stably transfected with a CAR expression cassette (B16F0-CAR), showed in the same experiment a 20-fold higher gene transfer efficiency. Interestingly, neither in B16F0 nor in B16F0-CAR tumors did we observe a reduction of gene transfer when injecting the CAR-ablated Ad vector F-S408E (data not shown). If CAR were the only difference between B16F0 and B16F0-CAR cells or tumors, one could argue that the S408E mutation is not sufficient to interfere with fiber knob/CAR interaction in the in vivo situation. It could be hypothesized that virus interaction with cells in vivo follows alternative pathways than in vitro, emphasizing the collaborative interaction of all three receptors (CAR, av integrins and HSPG) in addition to unknown adaptor molecules bridging CAR to S408E-mutated fiber knob. Interaction between adenoviral capsid and RGD or HSPG elements might be predominant in vivo and the lack of the CAR-binding motif does not therefore alter the infection behavior. Elimination of several of these elements, for example deletion of fiber knob AB loop, deletion of RGD motif in penton base and replacement of fiber shaft domain with that derived from Ad type 35 did indeed lead to liver de-targeting in vivo.
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Such multiple capsid-modified adenovirus vectors should thus be combined with fiber knob-exposed targeting ligand HEW. If the de-targeting capsid modifications do not impair steps beyond the natural receptor/ ligand interaction (virus uptake, release from endosomes, etc.), a targeting effect in vivo might become detectable. The generation of fiber-modified replication-competent adenoviruses, exemplified in, 29 with HEW exposed in the fiber knob domain might also favour to evidence retargeting effects in vivo: upon selective re-infection and amplification within the tumor mass, an amplification of the reporter gene expression might be achieved, enhancing small targeting effects. By these means HEW-mediated retargeting might become apparent in the in vivo situation.
In conclusion, the work described in this paper has demonstrated that the tumor cell specificity of the peptide ligand HEW could be transferred to replication-deficient adenoviral vectors. Insertion of this ligand in the exposed fiber knob domain of adenovirus vectors conferred increased infection of the target cell lines WiDr and MDA-MB435 cells in culture. Interaction between fiber knob-exposed HEW ligand and its target molecule could substitute for disturbed or non-existing fiber knob/CAR interaction and lead to efficient re-targeting of CARablated adenovirus vectors to WiDr and MDA-MB435 cells. Attempts to bring to the fore targeting and retargeting effects with HEW-carrying adenovirus vectors in WiDr-tumor-bearing animal models should be pursued and widened to include other tumor models such as MDA-MB435.
